ES2029832T3 - Procedimiento para la produccion de compuestos de macrolida. - Google Patents

Procedimiento para la produccion de compuestos de macrolida.

Info

Publication number
ES2029832T3
ES2029832T3 ES198787302099T ES87302099T ES2029832T3 ES 2029832 T3 ES2029832 T3 ES 2029832T3 ES 198787302099 T ES198787302099 T ES 198787302099T ES 87302099 T ES87302099 T ES 87302099T ES 2029832 T3 ES2029832 T3 ES 2029832T3
Authority
ES
Spain
Prior art keywords
compound
formula
production
procedure
macrolide compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787302099T
Other languages
English (en)
Inventor
Martin Todd
Mark A. Haxell
Gordon C. Lawrence
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2029832T3 publication Critical patent/ES2029832T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/445—The saccharide radical is condensed with a heterocyclic radical, e.g. everninomycin, papulacandin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Glass Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

UN PROCEDIMIENTO PARA LA OBTENCION DE UN COMPUESTO DE FORMULA (I), QUE CONSISTE EN CULTIVAR UN MICROORGANISMO DEL GENERO STREPTOMYCES CAPAZ DE PRODUCIR EL COMPUESTO DE FORMULA (I) EN PRESENCIA DE UNO O MAS ACIDOS GRASOS Y/O SALES, ESTERES Y AMIDAS DE DICHOS ACIDOS, MEDIANTE EL CUAL SE OBTIENE EL COMPUESTO DE FORMULA (I), Y EN AISLAR, SI SE DESEA, DICHO COMPUESTO. EL ACIDO GRASO AUMENTA LA PRODUCCION DEL COMPUESTO DE FORMULA (I), Y ES PREFERIBLEMENTE ACIDO ISOBUTIRICO O VALERICO.
ES198787302099T 1986-03-12 1987-03-11 Procedimiento para la produccion de compuestos de macrolida. Expired - Lifetime ES2029832T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868606120A GB8606120D0 (en) 1986-03-12 1986-03-12 Process

Publications (1)

Publication Number Publication Date
ES2029832T3 true ES2029832T3 (es) 1992-10-01

Family

ID=10594470

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787302099T Expired - Lifetime ES2029832T3 (es) 1986-03-12 1987-03-11 Procedimiento para la produccion de compuestos de macrolida.

Country Status (10)

Country Link
US (1) US5378617A (es)
EP (1) EP0241147B1 (es)
JP (1) JPH07106155B2 (es)
AT (1) ATE56975T1 (es)
CA (1) CA1319636C (es)
DE (1) DE3765157D1 (es)
DK (1) DK165124C (es)
ES (1) ES2029832T3 (es)
GB (1) GB8606120D0 (es)
IE (1) IE60058B1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
US5840704A (en) * 1986-07-16 1998-11-24 Pfizer Inc. Antiparasitic agents and process for their preparation
US5212322A (en) * 1986-12-11 1993-05-18 Sankyo Company, Limited Macrolide compounds, their preparation and their use
AR243528A1 (es) * 1986-12-11 1993-08-31 Sankyo Co Procedimiento para preparar compuestos de macrolida y un procedimiento para producir con los mismos una composicion parasiticida.
EP0284176B1 (en) * 1987-01-23 1993-08-25 Pfizer Inc. Process for production of avermectins and cultures therefor
US5234831A (en) * 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5525506A (en) * 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
IN167980B (es) * 1987-01-23 1991-01-19 Pfizer
US5238848A (en) * 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
PT88952B (pt) * 1987-11-09 1993-02-26 Pfizer Processo para a preparacao de avermectinas etiladas
GB8726730D0 (en) * 1987-11-14 1987-12-16 Pfizer Ltd Antiparasitic agents
JP2792856B2 (ja) * 1987-12-28 1998-09-03 山之内製薬株式会社 抗生物質の製造方法
GB8815967D0 (en) * 1988-07-05 1988-08-10 Pfizer Ltd Antiparasitic agents
US6103504A (en) * 1992-03-25 2000-08-15 Pfizer Inc. Process for production of avermectins and cultures therefor
CN104193760B (zh) * 2014-08-29 2016-11-30 宁夏泰瑞制药股份有限公司 一种利用奈马菌素发酵液提取奈马菌素粗品的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914624A (es) * 1972-06-08 1974-02-08
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
DE2909071A1 (de) * 1979-03-08 1980-09-11 Schmuecking Carl Guenther Epikutantestpflaster
ES8704545A1 (es) * 1984-09-14 1987-04-01 Glaxo Group Ltd Un procedimiento para preparar un nuevo antibiotico por fer-mentacion

Also Published As

Publication number Publication date
GB8606120D0 (en) 1986-04-16
DK125387A (da) 1987-09-13
DK165124C (da) 1993-03-01
US5378617A (en) 1995-01-03
JPS62272986A (ja) 1987-11-27
DK165124B (da) 1992-10-12
JPH07106155B2 (ja) 1995-11-15
DK125387D0 (da) 1987-03-11
ATE56975T1 (de) 1990-10-15
IE60058B1 (en) 1994-05-18
CA1319636C (en) 1993-06-29
EP0241147A1 (en) 1987-10-14
EP0241147B1 (en) 1990-09-26
DE3765157D1 (de) 1990-10-31
IE870626L (en) 1987-09-12

Similar Documents

Publication Publication Date Title
DK125387A (da) Fremgangsmaade til fremstilling af macrolidforbindelser
ES2073529T3 (es) Inhibidor de fosfolipasa a2, microorganismos que producen este inhibidor y procedimiento para su produccion.
NO921002L (no) Nye estere av tienylkarboksylsyrer og aminoalkoholer, deres kvartaeriseringsprodukter, og fremstilling og anvendelseav forbindelsene
NO176766C (no) Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
DE3687946D1 (de) Verfahren zur herstellung der 2-keto-l-gulonsaeure.
IT1236843B (it) Processo per la preparazione di 4-0-fosfati di dopamina o suoi derivati
DE3680938D1 (de) Verfahren zur herstellung von substituierten 3-chinolincarbonsaeuren.
ES547689A0 (es) Un procedimiento para la preparacion de un derivado de a-21978c
AU3406689A (en) Hydroxyacid ester intermediates useful for the production of substituted glutaric acid lactones
CA2002671A1 (en) Process for the production of 4,5-dichloro-6-ethyl-pyrimidine
ATE124691T1 (de) Antitumor- und antibiotikum-substanz, ihre herstellung und verwendungen.
BR9007752A (pt) Producao de acido glioxilico pela oxidacao enzimatica de acido glicolico
DE68912236D1 (de) Verfahren zur Herstellung von hochgradig ungesättigten Fettsäuren.
EP0230972A3 (en) Method of producing cephem compounds
EP0304049A3 (en) Method for the production of lipids containing bis-homo-linolenic acid
ES2130392T3 (es) Procedimiento para la preparacion de acido clavulanico.
HUT53377A (en) Process for producing antibiotic l 17392 (deglucoteicoplanin) and salts thereof
ES556415A0 (es) Un procedimiento para preparar compuestos de antraciclina
ES2144013T3 (es) Derivado de la vitamina d y procedimiento para su produccion.
AU8985891A (en) Method for the preparation of substituted and unsubstituted 2,3-pyridine and quinolinedicarboxylic acids
ES2051767T3 (es) Cetorreduccion estereoespecifica de esteres de acido carboxilico-biciclooctanodiona por microorganismos.
ES2092730T3 (es) Procedimiento microbiologico para la preparacion de acido 5-hidroxi-2-pirazina-carboxilico.
MX15078A (es) Procedimiento para la produccion de esteres del acido ftalazinacetico
ES2075154T3 (es) Un inhibidor de fosfolipasa a2, metodo para producirlo y formulaciones farmaceuticas o veterinarias que comprenden dicho inhibidor.
EP0247779A3 (en) Process for the production of substituted 2-oxocyclo-hexaneacetic acid esters

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 241147

Country of ref document: ES